Effect of ceftazidime/avibactam plus fosfomycin combination on 30 day mortality in patients with bloodstream infections caused by KPC-producing <i>Klebsiella pneumoniae</i>: results from a multicentre retrospective study
Alessandra Oliva(Sapienza University of Rome), Mario Venditti(Policlinico Umberto I), Francesco Cogliati Dezza(Sapienza University of Rome), S Agrenzano(Istituti di Ricovero e Cura a Carattere Scientifico), Stefania Stefani(University of Catania), Alessandra Mularoni(Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione), Cristian Borrazzo(Sapienza University of Rome), Maria Trancassini(Sapienza University of Rome), Lorenzo Volpicelli(Sapienza University of Rome), Andrea Cona(Istituti di Ricovero e Cura a Carattere Scientifico), Silvia Di Bari(Sapienza University of Rome), Ambrogio Curtolo(Sapienza University of Rome), F. Mengoni(Sapienza University of Rome), Giammarco Raponi(Policlinico Umberto I)
Cited by 35
Related Papers
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
|The Lancet Infectious Diseases|2017|521
Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by<i>Klebsiella pneumoniae</i>Carbapenemase–producing<i>K. pneumoniae</i>
|Clinical Infectious Diseases|2018|351
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing <i>K. pneumoniae</i> Infections: A Retrospective Observational Multicenter Study
|Clinical Infectious Diseases|2021|264
Mortality Attributable to Bloodstream Infections Caused by Different Carbapenem-Resistant Gram-Negative Bacilli: Results From a Nationwide Study in Italy (ALARICO Network)
|Clinical Infectious Diseases|2023|156
Outcome of Transplantation Using Organs From Donors Infected or Colonized With Carbapenem-Resistant Gram-Negative Bacteria
|American Journal of Transplantation|2015|136